España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ProPhase Labs
PRPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.750300
-0.02
-2.42%
Pre-Market: Nov 22, 4:37 PM EDT
Get Report
Comment
ProPhase Labs (PRPH) Forecast
News
Earnings
ProPhase Labs (PRPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ProPhase Labs (NASDAQ:PRPH) Stock
ProPhase Labs Stock (NASDAQ: PRPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
ProPhase Labs shares are trading lower after ...
Benzinga Newsdesk
ProPhase Labs Anticipates 'Significant 'Seque...
Benzinga Newsdesk
ProPhase Labs Q3 2024 GAAP EPS $(0.35) Misses...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
ProPhase Labs's Earnings: A Preview
Benzinga Insights
Friday, November 08, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
S&P 500 Tops 6,000; Sezzle Shares Spike Higher
Avi Kapoor
Dow Tops 44,000; US Consumer Sentiment Increases In November
Avi Kapoor
Why ProPhase Labs (PRPH) Stock Is Down 47% Today
Henry Khederian
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
ProPhase Labs shares are trading lower after ...
Benzinga Newsdesk
US Stocks Mixed; Fluor Earnings Miss Views
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, ProPhase Labs Prices $3M Pu...
Benzinga Newsdesk
Thursday, November 07, 2024
ProPhase Labs shares are trading lower after ...
Benzinga Newsdesk
ProPhase Labs Announced That Intends To Sell ...
Benzinga Newsdesk
Monday, November 04, 2024
ProPhase Labs Launches DNA Complete, To Enric...
Benzinga Newsdesk
Saturday, October 26, 2024
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
Anthony Noto
Thursday, October 17, 2024
ProPhase Labs Announces Updates On Strategic ...
Benzinga Newsdesk
Wednesday, August 14, 2024
ProPhase Labs Q2 2024 GAAP EPS $(0.33) Misses...
Benzinga Newsdesk
Thursday, July 11, 2024
ProPhase Labs Announces Update On Pharmaloz M...
Benzinga Newsdesk
Thursday, May 09, 2024
ProPhase Labs Q1 2024 GAAP EPS $(0.07) Beats ...
Benzinga Newsdesk
Tuesday, April 16, 2024
ProPhase Labs Unveils Project ZenQ-AI; Levera...
Benzinga Newsdesk
Wednesday, April 10, 2024
ProPhase Labs Seeks To Transform Esophageal C...
Benzinga Newsdesk
Friday, March 15, 2024
ProPhase Labs Q4 EPS $(0.51) Misses $(0.26) E...
Benzinga Newsdesk
Earnings Scheduled For March 15, 2024
Benzinga Insights
Thursday, March 14, 2024
ProPhase Labs's Earnings: A Preview
Benzinga Insights
Wednesday, February 21, 2024
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Tuesday, February 20, 2024
ProPhase Labs Announces Progress In BE-Smart Esophageal Cancer Test Development USPTO Grants Additional Broad Patents For BE-SMART
Happy Mohamed
Wednesday, February 14, 2024
ProPhase Labs Announces Preliminary Results F...
Benzinga Newsdesk
Tuesday, January 23, 2024
ProPhase Labs Announces Progress At Pharmaloz...
Benzinga Newsdesk
Thursday, January 04, 2024
Prophase Poised To Ramp Up Growth At Pharmalo...
Benzinga Newsdesk
Friday, November 10, 2023
HC Wainwright & Co. Maintains Buy on ProPhase...
Benzinga Newsdesk
Thursday, November 09, 2023
ProPhase Labs Q3 EPS $(0.30) Misses $(0.20) E...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
ProPhase Labs Earnings Preview
Benzinga Insights
Tuesday, October 17, 2023
Prophase Labs Inc Says Pharmaloz Plan Is To B...
Benzinga Newsdesk
Thursday, October 12, 2023
DSS Inc. Issues Letter To Shareholders Providing An Update On Progress So Far This Year And Expectations Going Into The End Of The Year
Happy Mohamed
Tuesday, August 29, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 28, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Friday, August 11, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
ProPhase Labs Q2 EPS $(0.20) Misses $(0.14) E...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Thursday, August 03, 2023
ProPhase Labs Teams Up With Certis Oncology T...
Benzinga Newsdesk
Wednesday, July 26, 2023
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
David Willey
-
Sponsored
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch